-
Palbociclib exposure in relation to efficacy and toxicity in patients with advanced breast cancer
Buijs, S. M., Mohmaed Ali, M. I., Oomen-de Hoop, E., Braal, C. L., Wortelboer, N., van Ommen-Nijhof, A., Sonke, G. S., Konings, I. R., Jager, A., Steeghs, N., Siebinga, H., Mathijssen, R. H. J., Huitema, A. D. R. & Koolen, S. L. W., 1 Mar 2025, In: ESMO open. 10, 3, 104290.Research output: Contribution to journal › Article* › Academic › peer-review
-
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
Sonke, G. S., van Ommen-Nijhof, A., Wortelboer, N., van der Noort, V., Swinkels, A. C. P., Blommestein, H. M., Guerrero Paez, C., Mol, L., Beeker, A., Beelen, K., Hamming, L. C., Heijns, J. B., Honkoop, A. H., de Jong, P. C., van Rossum-Schornagel, Q. C., van Schaik-van de Mheen, C., Tol, J., Tromp-van Driel, C. S., Vrijaldenhoven, S. & van Leeuwen-Stok, A. E. & 1 others, , 12 Dec 2024, In: Nature. 636, 8042, p. 474-480 7 p., 5.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
